DAX25.405 +0,6%Est506.016 +0,3%MSCI World4.343 -0,1%Top 10 Crypto12,13 -0,3%Nas23.734 +0,3%Bitcoin78.746 +0,8%Euro1,1662 -0,1%Öl64,28 ±-0,0%Gold4.581 -0,4%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 TKMS thyssenkrupp Marine Systems TKMS00 NVIDIA 918422 Novo Nordisk A3EU6F Bayer BAY001 Deutsche Telekom 555750 DroneShield A2DMAA RENK RENK73 Allianz 840400 Siemens Energy ENER6Y Amazon 906866 Lufthansa 823212 BASF BASF11 Infineon 623100 Volkswagen (VW) vz. 766403
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX etwas fester erwartet -- Asiens Börsen vorwiegend höher - Nikkei knackt Rekord -- EZB-Ausblick 2026: Zinserhöhung unwahrscheinlich -- Munich Re, DroneShield, Lufthansa, Nordex, UBS im Fokus
Top News
Lindt & Sprüngli-Aktie: Wachstum dank Preiserhöhungen - höher als erwartet Lindt & Sprüngli-Aktie: Wachstum dank Preiserhöhungen - höher als erwartet
US-Berichtssaison startet: DAX mit neuem Allzeithoch erwartet - kleine Gewinne voraus? US-Berichtssaison startet: DAX mit neuem Allzeithoch erwartet - kleine Gewinne voraus?
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
Verteidigung als Anlagechance: Mit diesem ETF erhältst du Zugang zu europäischen Unternehmen aus dem Luft-, Raumfahrt- und Verteidigungssektor

Quest Diagnostics Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
149,30 EUR -1,25 EUR -0,83 %
STU
175,91 USD +1,44 USD +0,82 %
BTT
Quest Diagnostics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.16,64 Mrd. EUR

KGV19,69Div. Rendite1,99%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN904533

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS74834L1008

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolDGX

Quest Diagnostics Aktien News

DatumMeistgelesen
PR NewswireGRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System
PR NewswireQuest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year
PR NewswireQuest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases Quarterly Dividend 6.7% to $0.80 Per Share
PR NewswireQuest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals
PR NewswireQuest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer
PR NewswireQuest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025
PR NewswireQuest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference
PR NewswireQuest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health
PR NewswireQuest Diagnostics Declares Quarterly Cash Dividend
PR NewswireQuest Diagnostics Awarded CDC Contracts for H5 Avian Influenza and Oropouche Virus Test Development
PR NewswireQuest Diagnostics Reports Third Quarter 2024 Financial Results; Updates Guidance for Full Year 2024
PR NewswireQuest Diagnostics Completes Acquisition of Lab Assets from OhioHealth
PR NewswireQuest Diagnostics to Release Third Quarter 2024 Financial Results on October 22, 2024
PR NewswireSentara Health Plans and Quest Diagnostics Form Strategic Collaboration to Extend Lab Access in Parts of the Southeast
PR NewswireQuest Diagnostics Completes Acquisition of Select Lab Assets from Allina Health
PR NewswireQuest Diagnostics to Speak at the Morgan Stanley 22nd Annual Global Healthcare Conference
PR NewswireQuest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation
PR NewswireQuest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation
PR NewswireQuest Diagnostics to Acquire University Hospitals' Outreach Laboratory Services Business
PR Newswirequesthealth.com Introduces 13 New Blood Tests to Identify Micronutrient Deficiencies
PR NewswireQuest Diagnostics Declares Quarterly Cash Dividend
PR NewswirePregnant Women Undertested for STIs, Finds Quest Diagnostics Health Trends® Study of Over 4 Million Pregnancies
PR NewswireQuest Diagnostics Named a "Best Place to Work for Disability Inclusion" for Seventh Straight Year
PR NewswireHaystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer
PR NewswireBD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases
PR NewswireQuest Diagnostics Reports Second Quarter 2024 Financial Results; Raises Guidance for Full Year 2024
PR NewswireQuest Diagnostics to Acquire Outreach Laboratory Services of OhioHealth
PR NewswireQuest Diagnostics to Acquire LifeLabs from OMERS, Enhancing Diagnostic Services for Canadians
PR NewswireQuest Diagnostics to Acquire LifeLabs from OMERS, Enhancing Diagnostic Services for Canadians
PR NewswireQuest Diagnostics Releases 2023 Corporate Responsibility Report
PR NewswireQuest Diagnostics to Acquire Select Lab Assets from Allina Health
PR NewswireQuest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024
PR NewswireQuest Diagnostics Completes Acquisition of Select PathAI Diagnostics' Lab Assets from PathAI, Accelerating Adoption of AI and Digital Pathology to Speed Cancer Diagnosis
PR NewswireBlood-based MRD Test for Cancer Recurrence Can Generate Cost Savings in Colorectal Cancer Treatment, Finds Study in JAMA Health Forum
PR NewswireQuest Diagnostics Elects Robert B. Carter, CIO of FedEx Corporation, to Board of Directors
PR NewswireQuest Diagnostics Declares Quarterly Cash Dividend
PR NewswireWorkforce Drug Test Cheating Surged in 2023, Finds Quest Diagnostics Drug Testing Index Analysis of Nearly 10 Million Drug Tests
PR NewswireQuest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference
PR NewswireQuest Diagnostics Names Murali Balakumar Senior Vice President and Chief Information and Digital Officer
PR NewswireQuest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI

Quest Diagnostics News

Quest Diagnostics News: auf dieser Seite finden Sie alle Quest Diagnostics News und Nachrichten zur Quest Diagnostics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Quest Diagnostics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Quest Diagnostics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.